SimpleChIP ® Plus Sonication Chromatin IP Kit

The chromatin immunoprecipitation (ChIP) assay is a powerful and versatile technique used for probing protein-DNA interactions within the natural chromatin context of the cell (1,2). This assay can be used to identify multiple proteins associated with a specific region of the genome, or the opposite, to identify the many regions of the genome bound by a particular protein (3-6). It can be used to determine the specific order of recruitment of various proteins to a gene promoter or to "measure" the relative amount of a particular histone modification across an entire gene locus (3,4). In addition to histone proteins, the ChIP assay can be used to analyze binding of transcription factors and co-factors, DNA replication factors and DNA repair proteins. When performing the ChIP assay, cells or tissues are first fixed with formaldehyde, a reversible protein-DNA cross-linking agent that "preserves" the protein-DNA interactions occurring in the cell (1,2). Cells are lysed and chromatin is harvested and fragmented using either sonication or enzymatic digestion. The chromatin is then immunoprecipitated with antibodies specific to a particular protein or histone modification. Any DNA sequences that are associated with the protein or histone modification of interest will co-precipitate as part of the cross-linked chromatin complex and the relative amount of that DNA sequence will be enriched by the immunoselection process. After immunoprecipitation, the protein-DNA cross-links are reversed and the DNA is purified. Standard PCR or Quantitative Real-Time PCR can be used to measure the amount of enrichment of a particular DNA sequence by a protein-specific immunoprecipitation (1,2). Alternatively, the ChIP assay can be combined with genomic tiling micro-array (ChIP on chip) techniques, high throughput sequencing, or cloning strategies, all of which allow for genome-wide analysis of protein-DNA interactions and histone modifications (5-8). 1.Orlando, V. (2000) Trends Biochem Sci 25, 99-104. 2.Liu, Q. et al. (2000) Genes Dev 14, 1448-59. 3.Kuo, M.H. and Allis, C.D. (1999) Methods 19, 425-33. 4.Zhao, H. and Piwnica-Worms, H. (2001) Mol Cell Biol 21, 4129-39. 5.Agalioti, T. et al. (2000) Cell 103, 667-78. 6.Jiang, K. et al. (2003) J Biol Chem 278, 25207-17. 7.Soutoglou, E. and Talianidis, I. (2002) Science 295, 1901-4. 8.Martin, S.A. and Ouchi, T. (2008) Mol Cancer Ther 7, 2509-16. 9.Mikkelsen, T.S. et al. (2007) Nature 448, 553-60. 10.Chen, M.S. et al. (2003) Mol Cell Biol 23, 7488-97. 11.Lee, T.I. et al. (2006) Cell 125, 301-13. 12.Zeng, Y. et al. (1998) Nature 395, 507-10. 13.Weinmann, A.S. and Farnham, P.J. (2002) Methods 26, 37-47. 14.Löffler, H. et al. (2006) Cell Cycle 5, 2543-7. 15.Wells, J. and Farnham, P.J. (2002) Methods 26, 48-56. 16.Zachos, G. et al. (2007) Dev Cell 12, 247-60. 17.Garber, K. (2005) J Natl Cancer Inst 97, 1026-8.